-
公开(公告)号:US5521160A
公开(公告)日:1996-05-28
申请号:US368519
申请日:1995-01-04
申请人: Alexander Chucholowski , Jurgen Fingerle , Niggi Iberg , Hans P. Marki , Rita Muller , Michael Pech , Marianne Rouge , Gerard Schmid , Thomas Tschopp , Hans P. Wessel
发明人: Alexander Chucholowski , Jurgen Fingerle , Niggi Iberg , Hans P. Marki , Rita Muller , Michael Pech , Marianne Rouge , Gerard Schmid , Thomas Tschopp , Hans P. Wessel
IPC分类号: C07D307/42 , A61K31/17 , A61K31/225 , A61K31/255 , A61K31/7024 , A61P9/10 , A61P9/14 , C07C31/18 , C07C31/27 , C07C305/04 , C07C305/06 , C07C305/10 , C07C305/16 , C07C309/02 , C07C311/17 , C07C311/23 , C07C317/22 , C07C317/36 , C07C317/44 , C07C335/06 , C07C335/16 , C07D303/46 , C07D307/68 , C07D311/82 , C07H7/00 , C07H11/00 , C07H5/04
CPC分类号: C07C305/10 , C07C305/06 , C07C311/17 , C07C317/22 , C07C317/36 , C07C317/44 , C07C335/16 , C07D307/68 , C07D311/82
摘要: The present invention is concerned with novel sulfuric acid esters of sugar alcohols and sugar alcohol-like compounds of the formula ##STR1## Also described are methods for the treatment and/or prophylaxis of arteriosclerotic changes in the vascular wall as well as a process for the manufacture of the compounds of formula I and their salts.
摘要翻译: 本发明涉及糖醇的新型硫酸酯和下式的糖醇类化合物(I)。还描述了治疗和/或预防血管壁动脉硬化变化的方法以及 用于制备式I化合物及其盐的方法。
-
公开(公告)号:US5830920A
公开(公告)日:1998-11-03
申请号:US639986
申请日:1996-04-26
申请人: Alexander Chucholowski , Jurgen Fingerle , Niggi Iberg , Hans Peter Marki , Rita Muller , Michael Pech , Marianne Rouge , Gerard Schmid , Thomas Tschopp , Hans Peter Wessel
发明人: Alexander Chucholowski , Jurgen Fingerle , Niggi Iberg , Hans Peter Marki , Rita Muller , Michael Pech , Marianne Rouge , Gerard Schmid , Thomas Tschopp , Hans Peter Wessel
IPC分类号: C07D251/70 , A61K31/165 , A61K31/27 , A61K31/35 , A61K31/352 , A61K31/53 , A61K31/70 , A61K31/7028 , A61P7/02 , A61P9/10 , A61P31/12 , A61P43/00 , C07C305/06 , C07C305/10 , C07D311/22 , C07H15/18 , A61K31/045 , C07C205/00
CPC分类号: C07H15/18 , C07C305/06 , C07C305/10
摘要: Compounds of the formula ##STR1## wherein n.sup.1 -n.sup.9 are each independently 0 or 1; m.sup.1 -m.sup.9 are each independently 0 or 1, but with the proviso that at least one of m.sup.1, m.sup.2 and m.sup.3, at least one of m.sup.4, m.sup.5 and m.sup.6 and, when present, at least one of m.sup.7, m.sup.8 and m.sup.9 is 1; and wherein X.sup.1 -X.sup.18 each independently is --O--, --CONR.sup.1,--NR.sup.1 CO-- or --NR.sup.1 --; R.sup.1 is hydrogen or lower alkyl; W is a benzene or s-triazine; Y.sup.1 -Y.sup.9 each independently is an aromatic ring systems; A.sup.1 -A.sup.3 each independently is a residue of a sugar alcohol devoid of the 1-hydroxy group or a derivative thereof, a residue of a sugar acid devoid of the 1-carboxy group or a derivative thereof or tris-(hydroxymethyl)-methyl; D is the di-residue of a sugar alcohol devoid of 2 hydroxy groups or a derivative thereof or the di-residue of a sugar dicarboxylic acid devoid of 2 carboxy group or a derivative thereof; Q.sup.1 -Q.sup.3 and Z.sup.1 -Z3 each independently are the di-residue of a sugar alcohol devoid of 2 hydroxy groups or a derivative thereof or the di-residue of a sugar dicarboxylic acid devoid of 2 carboxy groups or a derivative thereof or didesoxyglycopyranoside or a derivative thereof, wherein at least one hydroxy group of residues A.sup.1 -A.sup.3, D, Q.sup.1 -Q.sup.3 and Z.sup.1 -Z.sup.3 is esterified with sulfuric acid, and pharmaceutically usable salts thereof are useful for the treatment of disorders which are characterized by excessive or destructive proliferation of smooth muscle cells.
摘要翻译: 式Ia的化合物或其中n1-n9各自独立地为0或1; m1-m9各自独立地为0或1,但条件是m1,m2和m3中的至少一个,m4,m5和m6中的至少一个,并且当存在时,m7,m8和m9中的至少一个为1 ; 并且其中X1-X18各自独立地为-O - , - CONR1,-NR1CO-或-NR1-; R1是氢或低级烷基; W是苯或s-三嗪; Y1-Y9各自独立为芳环体系; A1-A3各自独立地为不含1-羟基或其衍生物的糖醇的残基,不含1-羧基的糖酸或其衍生物的残基或三 - (羟甲基) - 甲基; D是不含2个羟基的糖醇或其衍生物或不含2个羧基的糖二羧酸的二残基或其衍生物的二残基; Q1-Q3和Z1-Z3各自独立地为不含2个羟基的糖醇或其衍生物或不含2个羧基的糖二羧酸的二残基或其衍生物或二脱氧吡喃葡萄糖苷或二 其衍生物,其中残基A1-A3,D,Q1-Q3和Z1-Z3中的至少一个羟基用硫酸酯化,其药学上可用的盐可用于治疗以过度或破坏性增殖为特征的病症 的平滑肌细胞。
-
公开(公告)号:US5447919A
公开(公告)日:1995-09-05
申请号:US210115
申请日:1994-03-17
申请人: Markus Hosang , Niggi Iberg , Thomas B. Tschopp , Hans P. Wessel
发明人: Markus Hosang , Niggi Iberg , Thomas B. Tschopp , Hans P. Wessel
IPC分类号: A61K31/70 , A61K31/715 , A61P9/00 , A61P9/10 , C07H11/00
摘要: The use of compounds of the formula ##STR1## wherein R is hydrogen or a residue --SO.sub.3 M; M is a cation; and R' and R" are hydrogen or an .alpha.-glycosidically linked sulfated mono- or disaccharide residue; and at least one --SO.sub.3 M group is present per monosaccharide unit,as pharmaceutical compositions for the prevention and/or treatment of arteriosclerotic disorders and for the prevention of restenosis after invasive vascular surgery and after organ transplants.
摘要翻译: 使用其中R为氢或残基-SO 3 M的式(I)的化合物; M是阳离子; 和R'和R“是氢或α-糖苷酸连接的硫酸化单糖或二糖残基; 并且每个单糖单元存在至少一个-SO 3 M基团,作为用于预防和/或治疗动脉硬化障碍以及用于在侵入性血管手术后和器官移植后预防再狭窄的药物组合物。
-
公开(公告)号:US5767268A
公开(公告)日:1998-06-16
申请号:US639985
申请日:1996-04-26
申请人: Alexander Chucholowski , Jurgen Fingerle , Niggi Iberg , Hans Peter Marki , Rita Muller , Michael Pech , Marianne Rouge , Gerard Schmid , Thomas Tschopp , Hans Peter Wessel
发明人: Alexander Chucholowski , Jurgen Fingerle , Niggi Iberg , Hans Peter Marki , Rita Muller , Michael Pech , Marianne Rouge , Gerard Schmid , Thomas Tschopp , Hans Peter Wessel
IPC分类号: C07H5/04 , A61K31/70 , A61K31/7008 , A61P9/10 , A61P43/00 , C07H5/06 , C07H11/00 , C07H13/08 , C07H13/10 , C07H15/18 , C07H15/00
摘要: Compounds of formulas ##STR1## wherein, B is lower alkylene or an optionally substituted aromatic ring system; G.sup.1, G.sup.2 and G.sup.3 each independently signify a residue of a glycopyranoside, a glycopyranose or a derivative thereof, with at least one hydroxy group of residue G.sup.1, G.sup.2 or G.sup.3 being esterified with sulfuric acid, and pharmaceutically usable salts thereof, are useful for the treatment of disorders which are characterized by excessive or destructive proliferation of smooth muscle cells.
摘要翻译: 其中B为低级亚烷基或任选取代的芳族环系;其中B为低级亚烷基或任选取代的芳族环系; G1,G2和G3各自独立地表示具有至少一个残基G1,G2或G3的羟基被硫酸酯化的糖吡喃糖苷,糖吡喃糖或其衍生物的残基,及其药学上可用的盐可用于 治疗以平滑肌细胞过度或破坏性增殖为特征的疾病。
-
公开(公告)号:US5298616A
公开(公告)日:1994-03-29
申请号:US764511
申请日:1991-09-20
IPC分类号: A61K31/70 , A61K31/715 , A61P9/10 , C07H11/00 , C08B37/00
CPC分类号: C07H11/00
摘要: Sulphated O-Polysaccharide-trehaloses which can be used as medicaments, especially for the treatment of arteriosclerotic disorders.
摘要翻译: 硫酸化的多糖 - 海藻糖,可用作药物,特别是用于治疗动脉硬化性疾病。
-
-
-
-